VeriMom¿Es garcinia mangostana peel extract seguro durante el embarazo?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive hazard; peer‑reviewed literature contains pharmacology/toxicity studies but no consistent in vivo reproductive/teratology data indicating teratogenicity. Topical cosmetic exposure is expected to give low but measurable systemic exposure for typical extract constituents (PubChem/CosIng data), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised classification), PubMed (no clear reproductive/teratology evidence), PubChem/CosIng.
Pregnancy-safe products containing garcinia mangostana peel extract
Related ingredients
Frequently asked questions
- ¿Es garcinia mangostana peel extract seguro durante el embarazo?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive hazard; peer‑reviewed literature contains pharmacology/toxicity studies but no consistent in vivo reproductive/teratology data indicating teratogenicity. Topical cosmetic exposure is expected to give low but measurable systemic exposure for typical extract constituents (PubChem/CosIng data), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised classification), PubMed (no clear reproductive/teratology evidence), PubChem/CosIng.
- ¿Es garcinia mangostana peel extract seguro durante la lactancia?
- No authoritative evidence of reproductive or lactation-specific toxicity or harmonised hazard classifications. Lipophilic small molecules in extracts could theoretically transfer into milk if systemically absorbed, but no data demonstrating this for mangosteen peel extract or major xanthones; therefore hazard and mechanism remain 0 and exposure scored as low (1). Sources: ECHA Annex VI, PubMed, PubChem/CosIng.
- ¿Es garcinia mangostana peel extract seguro para la piel del bebé?
- No infant-specific reproductive or developmental toxicity data found; no regulatory flags. Because infant skin has higher absorption (immature barrier, higher surface‑area‑to‑weight), exposure rating increased by +1 relative to adults (adult exposure scored 1 → infant 2). No evidence to change hazard or mechanism. Sources: PubMed (no infant toxicity data), CosIng/PubChem (ingredient identity/properties), ECHA Annex VI (no harmonised classification).
- ¿Cómo puntúa VeriMom a garcinia mangostana peel extract?
- VeriMom puntúa garcinia mangostana peel extract en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a garcinia mangostana peel extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a garcinia mangostana peel extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.